First-in-class, oral PKM2 modulator, SYX-5219, has the potential to rebalance immune function and drive sustained disease remission Results from completed Phase 1a trial in healthy volunteers showed ...

Sitryx advances development of PKM2 modulator SYX-5219 into atopic dermatitis patients following clinical evidence of immunomodulatory activity First-in-class, oral PKM2 modulator, SYX-5219, has the ...

While most Junk Wax-era cards hold little value, one outlier continues to defy the era. A newly graded example has been confirmed as one of the rarest authentic versions of the card.

You will be redirected to our submission process. Immunomodulation has become a central concept in understanding how drugs influence human health across diverse disease conditions. Many commonly used ...